Widely read:
Stockwire
• Wealth Insight - May 2025
Analyst's Diary: Who's making your medicine?
The different drug development stages and the companies behind them
01-May-2025•Abhinav Goel
Top Picks
Welcome to the New Value Research!
2 min read•By Value Research
Why gold funds just shut their biggest taps
3 min read•By Ujjal Das
New episodes every Friday
Old file, new company
The market misprices stocks using outdated assumptions. The opportunity lies in that gap.
Other Episodes
-
When 'this too shall pass' doesn't
For 30 years, I have told readers to ride out every crisis. The US-Iran war is the exception, and the reason matters more than the news itself.
-
Read the signal, not the list
The Prime Minister's seven appeals are about consumption. The signal they carry is about the rupee.
-
The Omaha show is over
Sometimes waiting for too long can lead to missed opportunities
-
The straight-line trap
Why confident predictions about markets usually get the most important things wrong
More stories from Wealth Insight May 2025
Explore the edition
When markets fall, look within
3 min read•By Dhirendra Kumar
5 traps turning your portfolio red
13 min read•By Udhayaprakash
5 min read•By Value Research Team
'Diversification helps during volatile times'
10 min read•By Value Research Team
Market Reporter: Who made the news?
1 min read•By Value Research Team
1 min read•By Value Research Team
Market Barometer: The metrics that matter
1 min read•By Value Research Team
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
